Drug intelligence / Profile preview

deuterated oxytocin

Development stage
Phase 2
Lead developer
University of Chicago
Modality
Peptides
Administration
Intravenous
01

Overview

Deuterated oxytocin (specifically d5-oxytocin) is a stable isotope-labeled analogue of the nonapeptide hormone oxytocin. It is chemically identical to endogenous and synthetic unlabeled oxytocin, except for the substitution of five hydrogen atoms with deuterium. This modification does not significantly alter the biological activity of the molecule, allowing it to function as a potent agonist of the oxytocin receptor (OXTR). Upon binding, it triggers G-protein coupled signaling pathways that increase intracellular calcium levels, leading to the contraction of uterine smooth muscle (myometrium) and the mammary gland's myoepithelial cells. In clinical research settings, such as pharmacokinetic studies during cesarean deliveries, the deuterated label serves as a molecular tracer. This allows for the precise quantification of the exogenous dose's concentration in plasma using mass spectrometry, effectively distinguishing it from endogenous oxytocin levels and assisting in the optimization of dosing regimens to prevent postpartum hemorrhage.

Other names
d5-oxytocind-5-oxytocind 5-oxytocindeuterium-labeled oxytocinlabeled oxytocin
02

Targets

Oxytocin receptor

Beyond the preview

Go deeper on deuterated oxytocin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on deuterated oxytocin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call